Funding from Foundations/Private Sources
JHU's Corporate and Foundation Relations maintains a Web site listing upcoming grant competitions that are sponsored by foundations and other private sources: http://jhuresearch.jhu.edu/OCFR.htm. They are in addition to the limited-submission RFPs periodically announced by the Research Projects Administration office. The opportunities are listed in order of deadline and links to each funder's application information are provided. Contact Karin Hunt (firstname.lastname@example.org) with any questions.
Early-career clinicians who have an interest in
furthering neurofibromatosis research are invited to apply for the Francis
S. Collins Scholars Program in Neurofibromatosis Clinical and Translational
Research. The program provides two years of full salary support, stipends
for research costs, tuition for relevant coursework, travel costs for
scientific meetings and mentor stipends. The Francis S. Collins Scholars
Program in Neurofibromatosis Clinical and Translational Research is
named for Dr. Francis Collins in honor of his contribution to discovering
the NF1 gene and advancing translational science globally. When altered,
the NF1 gene leads to a high risk of tumor formation, particularly in
Applications are due February 10, 2014,
for funding that starts July 1, 2014. For more information about the
program and application guidelines, visit www.n-tap.org.
The American Asthma Foundation (AAF) supports highly innovative research from all fields relevant to asthma. We wish to draw outstanding investigators from other fields into the study of asthma, and most of our investigators are studying asthma for the first time. All grants will be to investigators who are within 10 years of their first independent faculty appointment. Recipients will be designated AAF Scholars.
AWARD AMOUNT: Up to $450,000 ($150,000
per year for up to 3 years.) Funds for institutional overhead are not
APPLICATION DEADLINE: February 12,
START DATE: July 1, 2014
ORGANIZATION: The American Asthma
Foundation is the largest private funder of asthma-related research,
having awarded over $100 million to scientists since 2000.
MISSION: The AAF's mission is to
improve treatments for, prevent, and find a cure for asthma by developing
important new pathways of investigation in basic research regarding
REVIEW CRITERIA: Innovation, research
proposal, relevance to asthma, investigator
NOTE: The application is short (maximum
7 pages). Preliminary data are not required.
FURTHER INFORMATION AT: http://americanasthmafoundation.org/
RESPONSE REQUESTED BY: Friday,
February 14, 2014
The Office of Research
Infrastructure Programs (ORIP) of the National Institutes of Health
(NIH) has announced a call for applications from NIH-supported investigators
for the purpose of purchasing or upgrading available instruments that
are priced greater than $100k. The most amount of funding that can be
requested from the Shared Instrument Grant Program is $600k (under the
NIH S10 mechanism). Instruments that could be supported from this funding
initiative include (but are not limited to) "confocal and electron
microscopes, biomedical images, mass spectrometers, DNA sequencers,
biosensors, cell-sorters, X-ray diffraction systems, and nuclear magnetic
resonance (NMR) spectrometers among others." These awards are for
one year only and do not require cost sharing. Potential projects should
have three or more Program Directors/Principal Investigators of NIH
research grants with one of the following activity codes - P01, R01,
U01, R35, R37, DP1 or DP2. NOTE: Multiple project directors or principal
investigators are not allowed under the NIH S10 mechanism.
Although Johns Hopkins
is not limited in the number of proposals it can submit, there should
be no duplication in the type of equipment proposed. In order
to avoid the possibility of any replication, interested candidates are
asked to submit the following in sequence in one PDF to email@example.com
no later than Friday, February 14, 2014:
This $100,000 grant
from the Bay Area Lyme Foundation has just been announced. Important
criteria include demonstrated professional and scientific leadership
in the biomedical sciences, ability to execute, and a strong supporting
scientific rationale for the project. The award recipient will be an
emerging researcher who embodies the future of leadership in Lyme disease
research and has identified a defined approach to improved diagnostics
or therapies for Lyme disease. Applicants must be affiliated with an
academic, research or industry organization. More details and an application
can be found at The full criteria and application for this award can
be found at http://www.bayarealyme.org/research/emerging-leader-award.
Applications will be accepted from researchers throughout the United
States through February 15, 2014.
DEADLINE: Tuesday, February
Reminder that the Damon
Runyon Cancer Research Foundation changed their application process
for 2014 and no longer require institutional nominations. Please see
their website for more details:
Deadline: March 15, 2014
innovative research projects that have the potential to advance the
implementation of personalized treatment for solid tumors are invited
to apply. Potential research topics which could be funded through the
GOI include: Research on molecular biomarkers or new targeted treatments,
technology platforms for the routine analysis of molecular biomarkers,
side effect management and platforms or tools which allow patients to
access individualized treatment.
A total grant of up
to € 1,000,000 will be awarded to one or more selected projects.
Applications will be
evaluated by a Scientific Steering Committee including internationally
renowned oncologists and researchers against the following criteria:
April 1, 2014 Electronic/April 2, 2014 Paper
There are various grants
available - for details see website: http://www.cancer.org/research/applyforaresearchgrant/granttypes/index
Howard Hughes Medical Institute is pleased to
announce a national competition for the appointment of outstanding scientists
as HHMI investigators. This competition will enable HHMI to strengthen
its community of basic researchers and physician scientists who bring
innovative approaches to the study of biological problems through biomedical
disciplines, including plant biology, as well as adjacent fields of
evolutionary biology, biophysics, chemical biology, biomedical engineering,
and computational biology.
This investigator competition places no restrictions on the number of applications from any eligible institution. Researchers with faculty appointments will apply directly; prior institutional endorsement is not part of the application process. These appointments are highly selective. Those candidates with outstanding records who have shown evidence of significant originality and accomplishments are encouraged to apply. HHMI welcomes applications from women and members of minority groups that are under-represented in biomedical sciences.
For additional information regarding the HHMI Investigator Program and this competition please link to: www.hhmi.org/inv2015.
The deadline for applications is June 3, 2014,
at 3:00 PM (Eastern Daylight Time). All applications must be submitted
electronically following instructions on the competition web site.
The application includes the following documents:
Selection of Investigators